Nomogram to Predict Progression-free Survival in Patients with Well-differentiated, Stage IV Gastroenteropancreatic Neuroendocrine Tumors Treated with Somatostatin Analogues: Data of TRASGU-GETNE Study

被引：0
|
作者：
Jimenez-Fonseca, P. [1 ]
Alonso, V [2 ]
Riesco, M. C. [3 ]
Custodio, A. [4 ]
Molina-Cerrillo, J. [5 ]
Sanchez Canovas, M. [6 ]
Benavent, M. [7 ]
Hernando Cubero, J. [8 ]
La Casta, A. [9 ]
Lopez, C. [10 ]
Marazuela Azpiroz, M. [11 ]
Carmona-Bayonas, A. [12 ]
机构：
[1] Hosp Univ Cent Asturias, Dept Med Oncol, Oviedo, Spain
[2] Hosp Univ Miguel Servet, Dept Med Oncol, Zaragoza, Spain
[3] Hosp Univ Doce Octubre, Dept Med Oncol, Madrid, Spain
[4] Hosp Univ La Paz, Dept Med Oncol, Madrid, Spain
[5] Hosp Univ Ramon & Cajal, Dept Med Oncol, Madrid, Spain
[6] Hosp Univ Morales Meseguer, Dept Med Oncol, Murcia, Spain
[7] Hosp Univ Virgen Rocio, Dept Med Oncol, Seville, Spain
[8] Hosp Univ Vall dHebron, Dept Med Oncol, Barcelona, Spain
[9] Hosp Univ Donostia, Dept Med Oncol, San Sebastian, Spain
[10] Hosp Univ Marques Valdecilla, Dept Med Oncol, Santander, Spain
[11] Complejo Hosp La Princesa, Dept Endocrinol, Madrid, Spain
[12] Univ Murcia, Hosp Univ Morales Meseguer Murcia, Dept Med Oncol, UMU,IMIB, Murcia, Spain
来源：
NEUROENDOCRINOLOGY | 2019年 / 108卷
关键词：
cox regression; prognosis; registry; tool;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
D28
引用
收藏
页码：67 / 67
页数：1
相关论文
共 31 条
  • [21] The CLARINET Study - Assessing the Effect of Lanreotide Autogel on Tumor Progression-Free Survival in Patients with Non-Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
    Joelle, Blumberg
    Nilani, Liyanage
    Martyn, Caplin
    PANCREAS, 2012, 41 (02) : 343 - 343
  • [22] Resection of the Primary Tumors Prolonged the Overall and Progression Free Survival in Patients with Neuroendocrine Neoplasms Stage IV Treated by Peptide Radionuclide Therapy (PRRT)
    Kaemmerer, Daniel
    Twiznik, Matthias
    Kulkrani, Harshad R.
    Hoersch, Dieter
    Sehner, Susanne
    Baum, Richard
    Hommann, Merten
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 192 - 192
  • [23] Metformin impact on progression-free survival in diabetic patients with advanced pancreatic neuroendocrine tumors (pNET) receiving everolimus and/or somatostatin analogues. The PRIME-NET (Pancreatic multicentric, Retrospective, Italian MEtformin) study
    Pusceddu, S.
    Marconcini, R.
    Spada, F.
    Cavalcoli, F.
    Ibrahim, T.
    Brizzi, M. P.
    Brighi, N.
    Faggiano, A.
    Puliafito, I.
    Delle Fave, G.
    Perfetti, V.
    Luppi, G.
    Carnaghi, C.
    Razzore, P.
    Davi, M. V.
    Cauchi, C.
    Duro, M.
    Di Maio, M.
    Buzzoni, R.
    Femia, D.
    De Braud, F.
    ANNALS OF ONCOLOGY, 2016, 27
  • [24] Metformin impact on progression-free survival in diabetic patients with advanced pancreatic neuroendocrine tumors (pNET) receiving everolimus and/or somatostatin analogues. The PRIME-NET (Pancreatic multicentric, Retrospective, Italian MEtformin) study
    Pusceddu, S.
    Marconcini, R.
    Spada, F.
    Massironi, S.
    Bongiovanni, A.
    Brizzi, M. P.
    Brighi, N.
    Colao, A.
    Giuffrida, D.
    Delle Fave, G.
    Cingarlini, S.
    Aroldi, F.
    Antonuzzo, L.
    Berardi, R.
    Catena, L.
    de Divitis, C.
    Ermacora, P.
    Di Maio, M.
    Buzzoni, R.
    de Braud, F.
    ANNALS OF ONCOLOGY, 2016, 27
  • [25] Impact of metformin on progression-free survival in diabetic patients with advanced pancreatic neuroendocrine tumors (pNETs) receiving everolimus and/or somatostatin analogues: A sensitivity analysis of the PRIME-NET (pancreatic multicentric, retrospective, italian metformin) study
    Pusceddu, Sara
    Vernieri, Claudio
    Di Maio, Massimo
    Daniela, Femia
    Prinzi, Natalie
    Marconcini, Riccardo
    Spada, Francesca
    Massironi, Sara
    Bongiovanni, Alberto
    Brizzi, Maria Pia
    Campana, Davide
    Faggiano, Antongiulio
    Giuffrida, Dario
    Delle Fave, Gianfranco
    Cingarlini, Sara
    Aroldi, Francesca
    Antonuzzo, Lorenzo
    Berardi, Rossana
    Catena, Laura
    Buzzoni, Roberto
    de Braud, Filippo
    CANCER RESEARCH, 2017, 77
  • [26] Prognostic factors for progression-free survival (PFS) in patients with metastatic bronchopulmonary neuroendocrine tumors (BP-NETs): Exploratory data from the phase 3 SPINET study
    Baudin, E.
    Hoersch, D.
    Singh, S.
    Caplin, M.
    Ferone, D.
    Wolin, E.
    Capdevila, J.
    Buikhuisen, W.
    Raderer, M.
    Houchard, A.
    Thanh, Truong X. M.
    Reidy-Lagunes, D.
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 166 - 166
  • [27] Nomogram based on MRI and clinical features to predict progression-free survival in patients with stage IIIC1r cervical squamous cell carcinoma: A two-center study
    Luo, W. -X.
    Ding, X. -M.
    Cheng, J. -M.
    Liu, X.
    Zhou, H. -Y.
    CLINICAL RADIOLOGY, 2024, 79 (08) : e1031 - e1039
  • [28] Evaluation of survival outcomes in patients with sporadic, advanced, unresectable well-differentiated pancreatic neuroendocrine tumors treated initially with octreotide LAR and subsequent therapeutical approaches on relapse. A real-world data set
    Kolasinska-Cwikla, Agnieszka
    Gutowska, Klaudia
    Osowiecka, Karolina
    Bednarczuk, Tomasz
    Sloniewska, Anna
    Roszkowska-Purska, Katarzyna
    Palucki, Jakub
    Cwikla, Jaroslaw B.
    ONCOLOGY IN CLINICAL PRACTICE, 2022, 18 (05): : 290 - 301
  • [29] Evaluation of PFS and OS in patients with sporadic, advanced, unresectable, well-differentiated pancreatic neuroendocrine tumors (NET) treated initially with Lanreotide AG and methods of further treatment approaches after progression real-world data
    Kolasinska-Cwikla, A.
    Lewczuk-Myslicka, A.
    Bednarczuk, T.
    Osowiecka, K.
    Sloniewska, A.
    Cwikla, J. B.
    JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 : 228 - 228
  • [30] Impact of Prior Somatostatin Analogue (SSA) Use on Progression-Free Survival (PFS) in Patients with Advanced Nonfunctional Neuroendocrine Tumors (NET) of Lung or Gastrointestinal (GI) Origin: A Secondary Analysis from the RADIANT-4 Study
    Buzzoni, R.
    Carnaghi, C.
    Pommier, R.
    Fazio, N.
    Singh, S.
    Voi, M.
    Pacaud, L.
    Ridolfi, A.
    Yao, J.
    Wolin, E.
    Pavel, M.
    Strosberg, J.
    NEUROENDOCRINOLOGY, 2016, 103 : 79 - 79
1234